Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intestinal mucosal and epithelial surface niches are specialized microenvironments within the gastrointestinal tract that facilitate the interaction between the host's epithelial lining, the underlying lamina propria, and the luminal microbiota (Nature Reviews Gastroenterology & Hepatology, 2020). These niches are essential for maintaining the intestinal barrier, which prevents the translocation of pathogens while allowing for the absorption of nutrients and water (Frontiers in Immunology, 2018). They also serve as the primary site for mucosal immunity, where specialized cells like M cells and dendritic cells sample antigens to educate the immune system (Cell Stem Cell, 2017). Within these niches, intestinal stem cells reside in the crypts, supported by a complex array of growth factors and stromal signals that ensure continuous epithelial renewal (Nature, 2011). In diseases such as inflammatory bowel disease (IBD) and celiac disease, the integrity of these niches is compromised, leading to chronic inflammation, dysbiosis, and tissue damage (PubMed, PMID: 30215168). While the niche itself is a multi-component environment rather than a single molecular target, it is the focal point for therapies aimed at mucosal healing, microbiome modulation, and local immune suppression (Gastroenterology, 2019). Drugs like vedolizumab target the trafficking of immune cells to these specific niches, while local agents like mesalamine act directly on the mucosal surface to reduce inflammation (Lancet, 2014).
Modulation of the local microenvironment, restoration of epithelial barrier integrity, and suppression of mucosal inflammation.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal mucosal and epithelial surface niches.